Advertisements



TherapeuticsMD up 1% to $5.25 after reopening following Annovera approval

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Cantor raises TherapeuticsMD target to $27 on Annovera approval

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 14th, 2018

TherapeuticsMD announces FDA approval of Annovera

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

TherapeuticsMD says FDA grants Annovera marketing exclusivity as a NCE

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 20th, 2018

TherapeuticsMD (TNXXF) FDA Approval Conference Call - Slideshow

TherapeuticsMD (TNXXF) FDA Approval Conference Call - Slideshow.....»»

Category: topSource: seekingalphaAug 14th, 2018

TherapeuticsMD Announces FDA Approval For Year-Round Contraceptive Ring

TherapeuticsMD Announces FDA Approval For Year-Round Contraceptive Ring.....»»

Category: topSource: seekingalphaAug 13th, 2018

FDA Approves New Form Of Self-Administered Female Birth Control

On Friday, TherapeuticsMD Inc (NASDAQ: TXMD) announced FDA approval of the first-ever patient-controlled long-acting reversible vaginal birth control system. read more.....»»

Category: blogSource: benzingaAug 10th, 2018

Senseonics up 5% after reopening following FDA approval news

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 21st, 2018

Your Daily Pharma Scoop: Crispr On Hold, AstraZeneca Stumbles Again, TherapeuticsMD Receives FDA Approval

Your Daily Pharma Scoop: Crispr On Hold, AstraZeneca Stumbles Again, TherapeuticsMD Receives FDA Approval.....»»

Category: topSource: seekingalphaMay 31st, 2018

TherapeuticsMD announces FDA approval of IMVEXXY to treat dyspareunia

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 30th, 2018

Cantor sees high likelihood of approval for TherapeuticsMD"s TX-004

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 21st, 2018

TherapeuticsMD talks with FDA "tacit sign" of approval, says Cantor Fitzgerald

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 12th, 2018

Corcept slides after Teva gets tentative approval for generic version of Korlym

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 30 min. ago

FDA reports tentative approval for Actavis" ANDA for Pimecrolimus

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 30 min. ago

30-Year TIPS Reopening Auctions With A Real Yield Of 1.235%

30-Year TIPS Reopening Auctions With A Real Yield Of 1.235%.....»»

Category: topSource: seekingalpha4 hr. 45 min. ago

State reopening applications for rural hospital tax credits

The state is reopening applications for Georgia's rural hospital tax credit program, the Department of Revenue announced this week. The program was reported to have reached its $60 million annual cap for the first time ever back in July. The agenc.....»»

Category: topSource: bizjournals6 hr. 15 min. ago

Ultragenyx announces approval of Mepsevii in Brazil for treatment of MPS VII

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall8 hr. 45 min. ago

Acorda: FDA"s pre-approval inspections at plants "successfully closed"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall8 hr. 45 min. ago

Takeda receives approval from JFTC for proposed Shire acquisition

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall8 hr. 45 min. ago

Takeda gets Japanese approval for Shire takeover, awaits EU nod

On Thursday, Takeda Pharmaceutical Co. Ltd. said that Japan's Fair Trade Commission has approved its $62 billion bid to acquire the second-largest biotech employer in Massachusetts, Shire Pharmaceuticals plc. According to Reuters, the deal has alre.....»»

Category: topSource: bizjournals12 hr. 0 min. ago

Takeda gets Japanese approval for $62 billion Shire purchase

Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc , bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker......»»

Category: topSource: reuters14 hr. 45 min. ago